Phase 1 study of NN-1406 in patients with type-2 diabetes mellitus
Latest Information Update: 12 Sep 2016
Price :
$35 *
At a glance
- Drugs NN 1406 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 12 Sep 2016 New trial record